Top compounds associated with response to CLDN10


Feature Type Standardized
Nominal ANOVA
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.00031 1
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.00026 1
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.00025 1
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.00015 1
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 4.6e-05 1
mRNA PHA-665752 GDSC1000 pan-cancer AAC 2.6e-05 1
Download CSV